Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows From Operating Activities:
Net loss	$ (6,871,406)	$ (2,482,187)
Adjustments to reconcile net loss to cash used in operating activities
Amortization of debt discount		285,858
Accrued interest		102,285
Change in fair value of warrant liability	(7,077,376)
Stock and option based compensation	4,829,484
Inducement expense	298,714
Depreciation and amortization expense	484,355
Change in operating assets and liabilities
Prepaid expenses and other current assets	320,123	(1,841)
Accounts payable and accrued liabilities	625,748	522,162
Due from related party		(65,075)
Net cash used in operating activities	(7,390,358)	(1,638,798)
Cash Flows From Investing Activities:
Purchase of Diverse Bio license agreement	(675,000)
Cash accretive acquisition of MagicMed	3,055,327
Net cash provided by investing activities	2,380,327
Cash Flows From Financing Activities:
Proceeds from sale of common stock and warrants, net of offering costs	21,614,488	227,500
Proceeds from convertible notes payable		50,000
Proceeds from note payable		1,812,410
Repayment of note payable		(157,714)
Proceeds from warrant exercises, net of fees	3,285,164
Net cash provided by financing activities	24,899,652	1,932,196
Effect of foreign exchange rate on cash	(19,655)	3,786
Net increase in cash	19,869,966	297,184
Cash - Beginning of period	1,578,460	43,714
Cash - End of period	21,448,426	340,898
Supplemental disclosure of cash and non-cash transactions:
Issuance of Common Stock pursuant to MagicMed amalgamation	39,042,282
Deferred tax liability incurred due to MagicMed amalgamation	9,061,927
Conversion of preferred stock to common stock$	32,754
Fair value of warrants issued	9,981,000
Fair value of Ameri warrants	262,492
Beneficial conversion feature issued with note payable		17,851
Warrants issued in conjunction with notes payable issuances		32,149
Common stock issued for accounts payable		173,482
Common stock issued in conjunction with note payable modification		45,725
Conversion of related party advances and notes payable into common stock		238,000
Cash paid for interest	5,191	388,143
Cash paid for income taxes